Table 3.
Clinical diagnosis of AEFI reports following DPT-IPV/Hib from 2015–2020
| Clinical diagnosis | No. of AEFI reports |
Reporting rate* | ROR-1.96SE | ||||
|---|---|---|---|---|---|---|---|
| Vaccine product-related reaction(minor) | Vaccine product-related reaction(severe) | Coincidental event | Anxiety reaction | Vaccination error | |||
| Aseptic abscess | 0 | 25 | 0 | 0 | 0 | 0.09 | 0.83 |
| Urticaria | 2 | 107 | 0 | 0 | 0 | 0.38 | 0.92 |
| Allergic purpura | 0 | 15 | 3 | 0 | 0 | 0.06 | 0.78 |
| Thrombocytopenic purpura | 0 | 12 | 3 | 0 | 0 | 0.05 | 0.92 |
| Angioedema | 0 | 21 | 0 | 0 | 0 | 0.07 | 0.53 |
| Febrile convulsion | 1 | 12 | 2 | 0 | 0 | 0.05 | 1.32 |
| Anaphylactic shock | 0 | 2 | 0 | 0 | 0 | 0.01 | 0.70 |
| Guillain Barre Syndrome | 0 | 5 | 6 | 0 | 0 | 0.04 | 1.16 |
| Epilepsy | 0 | 1 | 6 | 0 | 0 | 0.02 | 0.59 |
| Cellulitis | 0 | 0 | 4 | 0 | 10 | 0.05 | 0.62 |
| Acute disseminated encephalomyelitis | 0 | 2 | 3 | 0 | 0 | 0.02 | 0.73 |
| Allergic rash | 1202 | 0 | 0 | 0 | 0 | 4.20 | 1.36 |
| Fever/redness/induration | 4255 | 0 | 15 | 5 | 7 | 14.97 | 0.59 |
*: /10000 doses.